Recent Updates
Recently added Catalysts
AMGN

Amgen to Present at the 22nd Annual Oppenheimer Healthcare Conference Amgen (NASDAQ:AMGN) will participate in the Oppenheimer Healthcare Conference on Wednesday, Dec. 14, 2011, at the Waldorf Astoria Hotel in New York...

Key Takeaway: THOUSAND OAKS, Calif. , Dec. 9, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the Oppenheimer Healthcare Conference on Wednesday, Dec. 14, 2011 , at the Waldorf Astoria Hotel in New York City , beginning at 1:35 p.m. Eastern Time . Arvind Sood , vice president of

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif. , Dec. 9, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the Oppenheimer Healthcare Conference on Wednesday, Dec. 14, 2011 , at the Waldorf Astoria Hotel in New York City , beginning at 1:35 p.m. Eastern Time . Arvind Sood , vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.
CONTACT: Amgen, Thousand Oaks Christine Regan , 805-447-5476 (media) Arvind Sood , 805-447-1060 (investors)
Last updated: Dec 9, 2011